Patrick Mavingui

Research Director

CNRS Délégation Paris B
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Induced by the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the COVID-19 pandemic underlined the clear need for antivirals against coronaviruses. In an effort to identify new inhibitors of SARS-CoV-2, a screening of 824 extracts prepared from various parts of 400 plant species belonging to the Rutaceae and Annonaceae families was conducted using a cell-based HCoV-229E inhibition assay. Due to its significant activity, the ethyl acetate extract of the leaves of Clausena harmandiana was selected for further chemical and biological investigations. Mass spectrometry-guided fractionation afforded three undescribed phenolic lipids (1–3), whose structures were determined via spectroscopic analysis. The absolute configurations of 1 and 2 were determined by analyzing Mosher ester derivatives. The antiviral activity against SARS-CoV-2 was subsequently shown, with IC50 values of 0.20 and 0.05 µM for 2 and 3, respectively. The mechanism of action was further assessed, showing that both 2 and 3 are inhibitors of coronavirus entry by acting directly on the viral particle. Phenolic lipids from Clausena harmandiana might be a source of new antiviral agents against human coronaviruses.

Year:

2023

Year:

2023

Collaborators (7)

Chaker El Kalamouni

Associate Professor

Université de la Réunion

FRANCE
View details

Erwan Lagadec

University of Bergen

NORWAY
View details

Karin Séron

CNRS

FRANCE
View details

Sandrine Belouzard

Centre National de la Recherche Scientifique (CNRS)

FRANCE
View details

Steven Goodman

Field Museum of Natural History

UNITED STATES
View details

Pablo Tortosa

Professor

Université de la Réunion

FRANCE
View details

Cécile Apel

Université Paris-Saclay

FRANCE
View details